Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.940
-0.130 (-2.56%)
At close: Apr 1, 2025, 4:00 PM
4.930
-0.010 (-0.20%)
After-hours: Apr 1, 2025, 6:43 PM EDT

Cara Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-70.87-118.51-85.47-88.448.41
Upgrade
Depreciation & Amortization
0.190.260.251.551.02
Upgrade
Loss (Gain) From Sale of Assets
----0.07-
Upgrade
Asset Writedown & Restructuring Costs
4.27----
Upgrade
Loss (Gain) From Sale of Investments
-0.54-0.40.260.82-0.12
Upgrade
Stock-Based Compensation
8.9313.7317.7320.7914.84
Upgrade
Other Operating Activities
12.22.681.42--22.26
Upgrade
Change in Accounts Receivable
2.360.5-3.26--
Upgrade
Change in Inventory
-1.04-0.440.2-2.58-
Upgrade
Change in Accounts Payable
-21.443.285.68-1.02-2.78
Upgrade
Change in Income Taxes
0.7--0.81-0.69
Upgrade
Change in Other Net Operating Assets
4.326.84-15.548.06-3.89
Upgrade
Operating Cash Flow
-60.92-92.08-78.73-60.09-5.49
Upgrade
Capital Expenditures
-1.05-2.38-0.04-0.04-0.35
Upgrade
Sale of Property, Plant & Equipment
---0.07-
Upgrade
Investment in Securities
49.7945.84128.75-4.78-19.93
Upgrade
Investing Cash Flow
48.7443.46128.71-4.75-20.28
Upgrade
Issuance of Common Stock
-1.680.3146.6139.14
Upgrade
Other Financing Activities
-3.636.47---
Upgrade
Financing Cash Flow
-3.638.150.3146.6139.14
Upgrade
Net Cash Flow
-15.78-10.4750.29-18.2313.38
Upgrade
Free Cash Flow
-61.96-94.45-78.77-60.13-5.84
Upgrade
Free Cash Flow Margin
-868.19%-450.46%-188.15%-261.10%-4.32%
Upgrade
Free Cash Flow Per Share
-13.58-20.93-17.62-14.23-1.46
Upgrade
Levered Free Cash Flow
-44.23-52.53-48.35-26.51-9.67
Upgrade
Unlevered Free Cash Flow
-38.93-52.16-48.35-26.51-9.67
Upgrade
Change in Net Working Capital
12.14-12.1611.58-6.8728.54
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q